Retour
Prix Innovent Biologics, Inc. (1801.HK)
Graphique du cours de l'action 1801.HK
INNOVENT BIO (1801.HK)
Innovent Biologics, Inc.
HK$83.25
-2.17%
$-1.84
Marché fermé: Jan 20, 16:00:00 HKT
Statistiques clés
Clôture préc.
$85.35
Prix d'ouverture
$85.1
Plage de la journée
$82.75 - $86.05
Plage de 52 semaines
$30.75 - $109.1
Volume
6.0M
Volume moyen
14.1M
BPA (TTM)
0.74
Rendement en dividend
--
Capitalisation boursière
$143.2B
Qu’est-ce que INNOVENT BIO ?
Innovent Biologics, Inc. is a biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 6,190 full-time employees. The company went IPO on 2018-10-31. The pipeline covering monoclonal antibodies, multi-specific antibodies, immuno-cytokine, antibody-drug conjugates (ADCs), cell therapy and small molecules. The Company’s main products include TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), Pemazyre (pemigatinib) and others. The firm mainly conducts its businesses within domestic and overseas markets.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved